Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ACTRN12626000769381) titled 'Effect of dopamine on learning and cognition' on June 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Pharmacodynamics
Primary Sponsor: Edith Cowan University
Condition:
Parkinson's disease
Parkinson's disease
Neurological - Parkinson's disease
Intervention:
Oral administration of a single dose of Madopar (100 mg levodopa / 25 mg benserazide) or placebo, administered in a randomised, double-blind design. Madopar is a dopamine precursor that increases dopamine availability in the ...